For the three-month period ended September 2026, consolidated results show net sales of approximately 13,392 million yen, operating income of approximately 1,264 million yen, ordinary income of approximately 1,384 million yen, and net income attributable to owners of the parent of approximately 685 million yen. Profit improved due to increased sales of the electronic medical record system. An accompanying earnings briefing material is available. The forecast for the year-end dividend for the fiscal year ending September 2026 has been revised to omission of dividend (possible impact from the TOB initiated by SK-03).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4320","jir_company_name":"CE Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4320-20260805-04.pdf","jir_short_summary":"For the three-month period ended September 2026, consolidated results show net sales of approximately 13,392 million yen, operating income of approximately 1,264 million yen, ordinary income of approximately 1,384 million yen, and net income attributable to owners of the parent of approximately 685 million yen. Profit improved due to increased sales of the electronic medical record system. An accompanying earnings briefing material is available. The forecast for the year-end dividend for the fiscal year ending September 2026 has been revised to omission of dividend (possible impact from the TOB initiated by SK-03).","jir_summary":"### Overview of Results\nDuring the period, net sales increased year over year, with higher sales of the electronic medical record system contributing to profit growth. Segment-level results, including Healthcare Solutions and Marketing Solutions, remained solid in sales and profits, leading to higher operating income, ordinary income, and net income compared with the previous year. The smartphone service 'Doctor Connect' recorded impairment charges, but overall profit remained positive. Backlog trends show a decline, yet sales growth was maintained.\n\n### Outlook and Implications\nAgainst the backdrop of government initiatives promoting medical DX, the adoption of medical information systems such as electronic medical records is expected to continue. However, potential delays in server and networking equipment delivery and rising costs due to semiconductor supply-demand imbalances and a weaker yen may affect fourth-quarter and beyond performance. The company has announced an intention to omit the year-end dividend for fiscal 2026, and the impact of the TOB requires close monitoring.","jir_financial_highlights":"Net Sales: 13,292\u767e\u4e07\u5186 (YoY 7.9% increase)\nOperating Income: 1,364\u767e\u4e07\u5186 (YoY 14.1% increase)\nOrdinary Income: 1,384\u767e\u4e07\u5186 (YoY 14.9% increase)\nNet Income Attributable to Owners of the Parent: 685\u767e\u4e07\u5186 (YoY 4.6% increase)\nYear-end Dividend Forecast: No dividend (Revision as of earnings announcement)","jir_category":"","jir_hashtags":"#CEHoldings, #FinancialSummary, #MedicalDX","jir_key_figures":"Net Sales: 13,292\u767e\u4e07\u5186 (YoY +7.9%)\nOperating Income: 1,364\u767e\u4e07\u5186 (YoY +14.1%)\nOrdinary Income: 1,384\u767e\u4e07\u5186 (YoY +14.9%)","jir_meta_title":"CE Holdings | FY2026 3Q Financial Results Summary \u2014 Net Sales 13,292 million yen, Operating Income 1,364 million yen","jir_meta_description":"CE Holdings FY2026 3Q financial results overview. Segment trends, impairment charges, dividend policy, and other key points for investors.","jir_og_title":"CE Holdings | FY2026 3Q Financial Results Summary","jir_og_description":"Key points from CE Holdings' Q3 results. Revenue and profit trends, and outlook on dividends and medical DX market trends.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025_Q3\\\",\\\"2026_Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[12320,13292]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025_Q3\\\",\\\"2026_Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[1195,1364]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Healthcare Solutions\\\",\\\"Marketing Solutions\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[12917,375]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Profit Margin\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Healthcare Solutions\\\",\\\"Marketing Solutions\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Segment Profit\\\",\\\"data\\\":[1371,22]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Forecast vs Actual\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{}}\"}]","ir_related_company":58061,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-95956","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n